Anthony Bergeron

Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations

Anthony Bergeron, Gaëtan MacGrogan, Aurélie Bertaut et al. · Modern Pathology · 2021 · 40 citations · Full text

Breast Oncology, Specific Esrra Mutations, Medicine +6

Anticipating changes in the HER2 status of breast tumours with disease progression—towards better treatment decisions in the new era of HER2-low breast cancers

Anthony Bergeron, Aurélie Bertaut, Françoise Beltjens et al. · British Journal of Cancer · 2023 · 40 citations · Full text

Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing

Loïck Galland, Elise Ballot, Hugo Mananet et al. · npj Breast Cancer · 2022 · 24 citations · Full text

<scp>ER</scp>−/<scp>PR</scp>+ breast cancer: A distinct entity, which is morphologically and molecularly close to triple‐negative breast cancer

Françoise Beltjens, Damien Molly, Aurélie Bertaut et al. · International Journal of Cancer · 2021 · 21 citations · Full text

Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancers

Elise Ballot, Loïck Galland, Hugo Mananet et al. · Breast Cancer Research · 2022 · 14 citations · Full text